Vertie sells MD 77.43: Their patient advocacy approach to eligibility and enrollment reduces revenue cycle time from referral to remittance - improving patient satisfaction and boosting the bottom line for their clients.

Alegis manages more than $3 billion in charges for more than 240 hospitals nationwide and is focused on helping clients navigate the complex, and constantly evolving, federal and state regulatory environments in order to maximize revenue. Founded in 2008 by healthcare executives, Alegis specializes in revenue recovery on accounts that require heightened expertise, labor, and capital including third party eligibility, third-party liability, and account resolution and appeals. EDT to investors attending the Bank of America Merrill Lynch Global Healthcare Conference 2015 in London. On average, equities research analysts expect that MEDNAX will post $3.65 EPS for the current year. The business earned $676.60 million during the quarter, compared to analyst estimates of $677.02 million.


Soraya:
Deutsche Bank reaffirmed a buy rating and set a $79.00 target price (up previously from $77.00) on shares of MEDNAX in a research report on Saturday, May 23rd.

Autumn:
Stifel Nicolaus increased their price objective on MEDNAX from $90.00 to $91.00 and gave the stock a buy rating in a report on Tuesday, August 25th.

Patti:
Dougherty & Co upped their target price on MEDNAX from $88.00 to $90.00 and gave the company a buy rating in a report on Friday, July 31st.

Mertie:
The company ,through its subsidiaries, provides these services in the United States and Puerto Rico.

Leonora:
It is an affiliate of MEDNAX, Inc. (NYSE: MD), a national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology and other pediatric physicians services.

Nadia:
Starz recognized net sales of $417.7 million and net income of $63.0 million in its 2015 second financial quarter results.

Phylis:
Super Micro Computer Inc. declared its fourth fiscal quarter results with revenues of $573.6 million and net earnings of $26.7 million.

Gretchen:
The company reported net revenues of $676.6 million and net income of $84.1 million.

Eneida:
Mednax Inc has a market cap of $7.58 billion; its shares were traded at around $79.21 with a P/E ratio of 23.49 and P/S ratio of 2.96. Mednax Inc had an annual average earnings growth of 13.60% over the past 10 years.

Cathleen:
EDT to investors attending the Baird 2015 Healthcare Conference in New York City.

Mednax Inc (NYSE:MD)
//stockhand.net/us/?q=nyse%3Amd&id=559550